MATTHEW W FOEHR Insider Trading $RTTR Qualigen Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MATTHEW W FOEHR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MATTHEW W FOEHR. MATTHEW W FOEHR is President and COO in LIGAND PHARMACEUTICALS INC ($LGND) and Sr. VP Technical Operations in CONNETICS CORP ($CNCT) and Director in RITTER PHARMACEUTICALS INC ($RTTR) and Director in Viking Therapeutics, Inc. ($VKTX).
MATTHEW W FOEHR in Qualigen Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW W FOEHR: Director
Holdings: 100,174 shares
Current Value: $344,599
Latest Transaction: Apr 23 2020
$RTTR Market Capitalization: $36.80M
$RTTR Previous Close: $3.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MATTHEW W FOEHR in Qualigen Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CNCT, LGND, RTTR, VKTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 2020 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | D | 1.30 | 38,461 | 49,999 | 0 | |
| Apr 23 2020 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | C | 1.30 | 100 | 130 | 0 | |
| Apr 23 2020 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Grant | A | 0.00 | 38,461 | 0 | 138,635 | 100.2 K to 138.6 K (+38.39 %) |
| Apr 23 2020 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Buy | C | 0.00 | 76,923 | 0 | 100,174 | 23.3 K to 100.2 K (+330.84 %) |
| Jan 17 2020 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 0.23 | 12,000 | 2,760 | 12,000 | |
| Feb 08 2019 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 0.60 | 15,000 | 9,000 | 15,000 | |
| Nov 07 2018 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | P | 1.30 | 38,461 | 49,999 | 38,461 | |
| Nov 07 2018 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | P | 1.30 | 100 | 130 | 100 | |
| Aug 20 2018 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Buy | P | 2.04 | 19,751 | 40,292 | 54,751 | 35 K to 54.8 K (+56.43 %) |
| Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
| Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
| May 18 2017 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Buy | P | 0.62 | 18,000 | 11,155 | 35,000 | 17 K to 35 K (+105.88 %) |
| Nov 30 2016 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 2.37 | 7,000 | 16,590 | 7,000 | |
| Jan 11 2016 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Buy | P | 1.64 | 13,000 | 21,320 | 17,000 | 4 K to 17 K (+325.00 %) |
| Oct 15 2015 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 2.25 | 10,000 | 22,500 | 10,000 | |
| Jun 25 2015 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Buy | P | 5.00 | 4,000 | 20,000 | 4,000 | 0 to 4 K |
Page: 1